Patents by Inventor Ralph Schermuly

Ralph Schermuly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Invention Relating to Nanoparticles Containing Taxanes for Administration by Inhalation
    Publication number: 20210315829
    Abstract: Nanoparticles comprising at least three polymers, selected independently of one another from the list comprising PLGA, PLA, TPGS, TPGS-750M, PVA, LAEOLA/PLA-PEO-PLA, and also at least one active ingredient, selected from the list comprising paclitaxel, docetaxel and SB-T-1214. The particles have a core-shell structure, the core containing the at least one active ingredient and at least two polymers, the polymers being selected independently of one another from the list comprising RG502H, RG504, PLA, LAEOLA/PLA-PEO-PLA, TPGS and TPGS-750M, the shell containing PVA and/or TPGS. The nanoparticles are nebulizable.
    Type: Application
    Filed: September 4, 2018
    Publication date: October 14, 2021
    Inventors: Alexandra DALLA-BONA, Dr. Tobias GESSLER, Dr. Savai RAJKUMAR, Dr. Soni SAVAI PULLAMSETTI, Prof. Dr. Ralph SCHERMULY, Prof. Dr. Werner SEEGER
  • Use of Pde1c and Inhibitors Thereof
    Publication number: 20090030065
    Abstract: The present invention relates to the use of PDE1C as a novel target for the identification of compounds, which can be used for the treatment of pulmonary hypertension, fibrotic lung diseases or other fibrotic diseases outside the lung. The present invention further relates to the use of PDE1C inhibitors in the manufacture of pharmaceutical compositions for use in the therapy of those diseases.
    Type: Application
    Filed: June 13, 2006
    Publication date: January 29, 2009
    Applicant: NYCOMED GmbH
    Inventors: Torsten Dunkern, Armin Hatzelmann, Friedrich Grimminger, Ralph Schermuly
  • Novel use of guanylate cyclase activators for the treatment of respiratory insufficiency
    Publication number: 20050181066
    Abstract: The invention relates to the novel use of guanylate cyclase activators for the treatment of partial and global respiratory failure.
    Type: Application
    Filed: April 24, 2003
    Publication date: August 18, 2005
    Applicant: Altana Pharma AG
    Inventors: Friedrich Grimminger, Ralph Schermuly, Christian Schudt